MedTrace Logo

Alzheimer's Disease and Related Dementias (ADRD) Prevalence in American Samoa

NCT05924529 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1098

Last updated 2023-06-29

No results posted yet for this study

Summary

The goal of this study is to learn about ADRD prevalence within the Samoan population. Participants will be administered a series of cognitive assessments to determine cognitive status and a population-based prevalence of Mild Cognitive Impairment (MCI) and ADRD. Blood samples will also be collected from the participants for genetic and plasma biomarker analysis.

Conditions

  • Alzheimer's Disease and Related Dementia

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of Miami

    collaborator OTHER

  • University of California, San Francisco

    collaborator OTHER

  • University of Hawaii

    collaborator OTHER

  • American Samoa Community Cancer Coalition

    lead OTHER

Principal Investigators

  • Va'atausili Tofaeono, MS · American Samoa Community Cancer Coalition

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • American Samoa

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05924529 on ClinicalTrials.gov